Last reviewed · How we verify

NCT03634748: TRUST CT

Thrombolysis in stRoke With Unknown onSet Based on noncontrasT CT

Completed Last updated 4 February 2019
What this trial tests

trial in Stroke, Acute in 117 participants. Completed in 31 December 2018.

Timeline
1 September 2017
Primary endpoint
31 December 2018
31 December 2018

Quick facts

Lead sponsorUniversity Hospital Tuebingen
StatusCompleted
Study typeOBSERVATIONAL
Enrollment117
Start date1 September 2017
Primary completion31 December 2018
Estimated completion31 December 2018
Sites5 locations across Austria, Slovakia, Switzerland, Germany

Conditions studied

Sponsor

University Hospital Tuebingen

Who can join

18 and older, any sex, with Stroke, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Multicentric, observational, registry-based study of 0.9 mg/kg i.v. thrombolysis in wake-up stroke or stroke with unknown onset based on non-contrast CT appearance only

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Thrombolysis in Stroke With Unknown Onset Based on Non-Contrast Computerized Tomography (TRUST CT).
    Sykora M, Kellert L, Michel P, Eskandari A, et al · · 2020 · cited 18× · PMID 32067594 · DOI 10.1161/jaha.119.014265
  2. E-Poster Viewing
    · 2019 · cited 2×

Verify or expand the search:

Other recruiting trials for Stroke, Acute

Currently open trials in the same condition.

Other University Hospital Tuebingen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03634748.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing